5-n-butyl-2,4-dihydro-2-<2-(trifluoromethyl)phenyl>-3H-1,2,4-triazol-3-one | 146948-93-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 5-n-butyl-2,4-dihydro-2-<2-(trifluoromethyl)phenyl>-3H-1,2,4-triazol-3-one
• 英文别名: 3-butyl-1-(2-(trifluoromethyl)phenyl)-1H-1,2,4-triazol-5(4H)-one；5-n-butyl-2,4-dihydro-2-[2-(trifluoromethyl)phenyl]-3H-1,2,4-triazol-3-one；5-butyl-2-(2-trifluoromethylphenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one；5-n-Butyl-2,4-dihydro-2-[2-(trifluoromethyl)phenyl]-3H-1,2,4-triazol-3-one；5-butyl-2-[2-(trifluoromethyl)phenyl]-4H-1,2,4-triazol-3-one
• CAS: 146948-93-8
• 化学式: C₁₃H₁₄F₃N₃O
• 分子量: 285.269
• InChiKey: RWUMUQHFDIJVPJ-UHFFFAOYSA-N

物化性质

• 密度：
  1.32±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  20
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  44.7
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  5-n-butyl-2,4-dihydro-2-<2-(trifluoromethyl)phenyl>-3H-1,2,4-triazol-3-one 在 sodium hydride 、 溶剂黄146 作用下， 以 水 为溶剂， 反应 2.83h， 生成 5-Butyl-4-[2'-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-2-(2-trifluoromethyl-phenyl)-2,4-dihydro-[1,2,4]triazol-3-one
  参考文献：
  名称：

  Triazolinones as nonpeptide angiotensin II antagonists. 1. Synthesis and evaluation of potent 2,4,5-trisubstituted triazolinones

  摘要：

  A series of 2,4-dihydro-2,4,5-trisubstituted-3H-1,2,4-triazol-3-ones was prepared via several synthetic routes and evaluated as AII receptor antagonists in vitro and in vivo. The preferred compounds contained a [2'-(5-tetrazolyl)biphenyl-4-yl]methyl side chain at N4 and an n-butyl group at C5. A number of these bearing an alkyl or aralkyl substituent at N2 showed in vitro potency in the nanomolar range (rabbit aorta membrane receptor), and several of these, e.g., the 2,2-dimethyl-1-propyl analogue (54, IC50 = 2.1 nM), effectively blocked the AII pressor response in conscious rats with significant duration (2.5 h at 1 mg/kg orally for 54). Among analogues possessing aryl substituents at N2, ortho substitution on the phenyl moiety resulted in several derivatives with in vitro potency in the low nanomolar range. One of these, featuring a 2-(trifluoromethyl)phenyl substituent at N2 (25, IC50 = 1.2 nM), was effective at 1 mg/kg orally in the rat model, with a duration of >6 h. Implications for hydrophobic and hydrogen-bonding interactions with the AT1 receptor are discussed.

  DOI：

  10.1021/jm00069a015
• 作为产物：
  描述：

  ethyl valerimidate 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 3.5h， 生成 5-n-butyl-2,4-dihydro-2-<2-(trifluoromethyl)phenyl>-3H-1,2,4-triazol-3-one
  参考文献：
  名称：

  Triazolinones as nonpeptide angiotensin II antagonists. 1. Synthesis and evaluation of potent 2,4,5-trisubstituted triazolinones

  摘要：

  A series of 2,4-dihydro-2,4,5-trisubstituted-3H-1,2,4-triazol-3-ones was prepared via several synthetic routes and evaluated as AII receptor antagonists in vitro and in vivo. The preferred compounds contained a [2'-(5-tetrazolyl)biphenyl-4-yl]methyl side chain at N4 and an n-butyl group at C5. A number of these bearing an alkyl or aralkyl substituent at N2 showed in vitro potency in the nanomolar range (rabbit aorta membrane receptor), and several of these, e.g., the 2,2-dimethyl-1-propyl analogue (54, IC50 = 2.1 nM), effectively blocked the AII pressor response in conscious rats with significant duration (2.5 h at 1 mg/kg orally for 54). Among analogues possessing aryl substituents at N2, ortho substitution on the phenyl moiety resulted in several derivatives with in vitro potency in the low nanomolar range. One of these, featuring a 2-(trifluoromethyl)phenyl substituent at N2 (25, IC50 = 1.2 nM), was effective at 1 mg/kg orally in the rat model, with a duration of >6 h. Implications for hydrophobic and hydrogen-bonding interactions with the AT1 receptor are discussed.

  DOI：

  10.1021/jm00069a015

文献信息

• Substituted triazolinones, triazolinethiones, and triazolinimines as
  申请人：Merck & Co., Inc.

  公开号：US05411980A1

  公开（公告）日：1995-05-02

  There are disclosed new substituted triazolinone, triazolinethione, and triazolinimine compounds which are useful as angiotensin II antagonists. These compounds have the general formula: ##STR1## wherein G is R.sup.1 or ##STR2##

  已披露了新的取代三唑酮，三唑硫酮和三唑亚胺化合物，这些化合物可用作血管紧张素II拮抗剂。这些化合物具有一般式：##STR1## 其中G为R.sup.1或##STR2##
• Triazolinone Biphenylsulfonamide Derivatives as Orally Active Angiotensin II Antagonists with Potent AT1 Receptor Affinity and Enhanced AT2 Affinity
  作者：Wallace T. Ashton、Linda L. Chang、Kelly L. Flanagan、Steven M. Hutchins、Elizabeth M. Naylor、Prasun K. Chakravarty、Arthur A. Patchett、William J. Greenlee、Tsing-Bau Chen

  DOI：10.1021/jm00043a020

  日期：1994.8

  cycloalkylcarbonyl derivatives. Certain other acidic sulfonamides, such as sulfonylcarbamates and disulfimides also displayed high affinity for the AT1 receptor. In addition, AT2 binding for some of these compounds was increased by as much as 1000-fold over the corresponding tetrazole (e.g., AT2 IC50 17 nM for the tert-butyl sulfonylcarbamate 92). When evaluated for inhibition of the AII pressor response, the benchmark

  几个系列的2,4-二氢-2,4,5-三取代的3H-1,2,4-三唑-3-酮在联苯-4-基甲基的2'-位上被四唑的酸性磺酰胺取代制备N4链并作为血管紧张素II（AII）拮抗剂进行测试。三唑啉酮环上的优选取代基是在C5处的正丁基和在N2处的2-（三氟甲基）苯基。对于多种酰基磺酰胺，包括芳酰基，杂芳酰基和环烷基羰基衍生物，观察到AT1受体亚型的亚纳摩尔IC50值。某些其他酸性磺酰胺，如磺酰氨基甲酸酯和二硫化亚胺也对AT1受体表现出高亲和力。另外，这些化合物中某些化合物的AT2结合量比相应的四唑增加了1000倍（例如，叔丁基磺酰基氨基甲酸酯92的AT2 IC50 17 nM）。当评估抑制AII升压反应时，基准苯甲酰磺酰胺9（L-159,913）在几种物种中均有效，在有意识的恒河猴中优于氯沙坦（1a）。随后的几种类似物，包括2-氯苯甲酰基（18），（3-氯噻吩-2-基）羰基（51），（（S）-2,2
• Synthesis of 3<i>H</i>-1,2,4-Triazol-3-ones via NiCl₂-Promoted Cascade Annulation of Hydrazonoyl Chlorides and Sodium Cyanate
  作者：Shiying Du、Zuguang Yang、Jianhua Tang、Zhengkai Chen、Xiao-Feng Wu

  DOI：10.1021/acs.orglett.1c00568

  日期：2021.3.19

  A nickel-promoted cascade annulation reaction for the facile synthesis of 3H-1,2,4-triazol-3-ones from readily available hydrazonoyl chlorides and sodium cyanate has been developed. The transformation occurs through a cascade nickel-promoted intermolecular nucleophilic addition–elimination process, intramolecular nucleophilic addition, and a hydrogen-transfer sequence. The method has been successfully

  已经开发了镍促进的级联环化反应，用于从容易获得的酰肼基氯和氰酸钠容易地合成3 H -1,2,4-三唑-3-酮。通过级联镍促进的分子间亲核加成-消除过程，分子内亲核加成和氢转移序列进行转化。该方法已成功应用于血管紧张素II拮抗剂的核心骨架的构建。
• Substituted 1,2,4-triazoles bearing acidic functional groups as
  申请人：Merck & Co., Inc.

  公开号：US05281614A1

  公开（公告）日：1994-01-25

  Novel substituted triazolinone, triazolinethione, and triazolinimine compounds of the formula I are useful as angiotensin II antagonists. ##STR1##

  这些公式I中的新型替代三唑酮，三唑硫酮和三唑亚胺化合物可用作抗血管紧张素II拮抗剂。
• Angiotensin II antagonists incorporating a substituted thiophene or furan
  申请人：MERCK & CO. INC.

  公开号：EP0510812A1

  公开（公告）日：1992-10-28

  Substituted heterocycles attached through a methylene bridge to novel substituted phenyl thiophene or phenyl furan derivative of the Formula I are useful as angiotensin II antagonists.

  通过亚甲基桥连接到式 I 的新型取代苯基噻吩或苯基呋喃衍生物上的取代杂环可用作血管紧张素 II 拮抗剂。